Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...

Alphabet stock shifts to a hold as market cap nears valuation peak. Explore the impact of AI, Google Cloud growth, and future ...

Here's everything to know about the Group 7 trend, which originated from a series of videos posted by musician Sophia James Jordana Comiter is an Associate Editor on the Evergreen team at PEOPLE. She ...

The "Group 7" trend has taken social media by storm this week. Are you in "Group 7?" There's only one way to find out (open TikTok), and there is nothing you can do to change your group. These are the ...

Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial Intelligence. Isomorphic Labs, a drug discovery company spun out of Google DeepMind, ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

Alphabet’s drug discovery arm, Isomorphic Labs, is preparing to enter a new chapter in its ambitious efforts to reshape medicine through artificial intelligence, with its first human clinical trials ...

In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed ...

Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. As Chief Medical Officer, Dr. Wolf will bring his ...